Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 198 entries
Sorted by: Best Match Show Resources per page
Behavioral Economics and Ambulatory Antibiotic Stewardship: A Narrative Review.

Clinical therapeutics

Richards AR, Linder JA.
PMID: 34702589
Clin Ther. 2021 Oct;43(10):1654-1667. doi: 10.1016/j.clinthera.2021.08.004. Epub 2021 Oct 23.

PURPOSE: Behavioral economics recognizes that contextual, psychological, social, and emotional factors powerfully influence decision-making. Behavioral economics has the potential to provide a better understanding of, and, through subtle environmental changes, or "nudges," improve persistent quality-of-care challenges, like ambulatory antibiotic...

Cite
Richards AR, Linder JA. Behavioral Economics and Ambulatory Antibiotic Stewardship: A Narrative Review. Clin Ther. 2021;43(10):1654-1667doi: 10.1016/j.clinthera.2021.08.004.
Richards, A. R., & Linder, J. A. (2021). Behavioral Economics and Ambulatory Antibiotic Stewardship: A Narrative Review. Clinical therapeutics, 43(10), 1654-1667. https://doi.org/10.1016/j.clinthera.2021.08.004
Richards, Alexandra R, and Linder, Jeffrey A. "Behavioral Economics and Ambulatory Antibiotic Stewardship: A Narrative Review." Clinical therapeutics vol. 43,10 (2021): 1654-1667. doi: https://doi.org/10.1016/j.clinthera.2021.08.004
Richards AR, Linder JA. Behavioral Economics and Ambulatory Antibiotic Stewardship: A Narrative Review. Clin Ther. 2021 Oct;43(10):1654-1667. doi: 10.1016/j.clinthera.2021.08.004. Epub 2021 Oct 23. PMID: 34702589; PMCID: PMC8612959.
Copy Download .nbib Format: NLM
In Vitro Models for the Study of the Intracellular Activity of Antibiotics.

Methods in molecular biology (Clifton, N.J.)

Peyrusson F, Nguyen TK, Buyck JM, Lemaire S, Wang G, Seral C, Tulkens PM, Van Bambeke F.
PMID: 34590263
Methods Mol Biol. 2021;2357:239-251. doi: 10.1007/978-1-0716-1621-5_16.

Intracellular bacteria are poorly responsive to antibiotic treatment. Pharmacological studies are thus needed to determine the antibiotics which are the most potent or effective against intracellular bacteria as well as to explore the reasons for poor bacterial responsiveness. An...

Cite
Peyrusson F, Nguyen TK, Buyck JM, et al. In Vitro Models for the Study of the Intracellular Activity of Antibiotics. Methods Mol Biol. 2021;2357:239-251doi: 10.1007/978-1-0716-1621-5_16.
Peyrusson, F., Nguyen, T. K., Buyck, J. M., Lemaire, S., Wang, G., Seral, C., Tulkens, P. M., & Van Bambeke, F. (2021). In Vitro Models for the Study of the Intracellular Activity of Antibiotics. Methods in molecular biology (Clifton, N.J.), 2357239-251. https://doi.org/10.1007/978-1-0716-1621-5_16
Peyrusson, Frédéric, et al. "In Vitro Models for the Study of the Intracellular Activity of Antibiotics." Methods in molecular biology (Clifton, N.J.) vol. 2357 (2021): 239-251. doi: https://doi.org/10.1007/978-1-0716-1621-5_16
Peyrusson F, Nguyen TK, Buyck JM, Lemaire S, Wang G, Seral C, Tulkens PM, Van Bambeke F. In Vitro Models for the Study of the Intracellular Activity of Antibiotics. Methods Mol Biol. 2021;2357:239-251. doi: 10.1007/978-1-0716-1621-5_16. PMID: 34590263.
Copy Download .nbib Format: NLM
Antibiotic Resistance of Human Periodontal Pathogen .

Antibiotics (Basel, Switzerland)

Rams TE, Sautter JD, van Winkelhoff AJ.
PMID: 33080856
Antibiotics (Basel). 2020 Oct 17;9(10). doi: 10.3390/antibiotics9100709.

Changes were evaluated over 10 years in the in vitro resistance of human periodontopathic strains of

Cite
Rams TE, Sautter JD, van Winkelhoff AJ. Antibiotic Resistance of Human Periodontal Pathogen . Antibiotics (Basel). 2020;9(10)doi: 10.3390/antibiotics9100709.
Rams, T. E., Sautter, J. D., & van Winkelhoff, A. J. (2020). Antibiotic Resistance of Human Periodontal Pathogen . Antibiotics (Basel, Switzerland), 9(10), . https://doi.org/10.3390/antibiotics9100709
Rams, Thomas E, et al. "Antibiotic Resistance of Human Periodontal Pathogen ." Antibiotics (Basel, Switzerland) vol. 9,10 (2020). doi: https://doi.org/10.3390/antibiotics9100709
Rams TE, Sautter JD, van Winkelhoff AJ. Antibiotic Resistance of Human Periodontal Pathogen . Antibiotics (Basel). 2020 Oct 17;9(10). doi: 10.3390/antibiotics9100709. PMID: 33080856; PMCID: PMC7602954.
Copy Download .nbib Format: NLM
Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro.

Antibiotics (Basel, Switzerland)

Stolte M, Ali W, Jänis J, Gessner A, El-Najjar N.
PMID: 32521723
Antibiotics (Basel). 2020 Jun 08;9(6). doi: 10.3390/antibiotics9060309.

Flucloxacillin (FLU), an isoxazolyl penicillin, is widely used for the treatment of different bacterial infections in intensive care units (ICU). Being highly bound to plasma proteins, FLU is prone to drug-drug interactions (DDI) when administered concurrently with other drugs....

Cite
Stolte M, Ali W, Jänis J, et al. Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro. Antibiotics (Basel). 2020;9(6)doi: 10.3390/antibiotics9060309.
Stolte, M., Ali, W., Jänis, J., Gessner, A., & El-Najjar, N. (2020). Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro. Antibiotics (Basel, Switzerland), 9(6), . https://doi.org/10.3390/antibiotics9060309
Stolte, Maximilian, et al. "Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro." Antibiotics (Basel, Switzerland) vol. 9,6 (2020). doi: https://doi.org/10.3390/antibiotics9060309
Stolte M, Ali W, Jänis J, Gessner A, El-Najjar N. Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro. Antibiotics (Basel). 2020 Jun 08;9(6). doi: 10.3390/antibiotics9060309. PMID: 32521723; PMCID: PMC7345279.
Copy Download .nbib Format: NLM
[Results of the Program for the Rational Use of Antimicrobials in a Mexican hospital, 2013-2018Resultados de um programa para o uso racional de antimicrobianos num hospital no México, 2013-2018].

Revista panamericana de salud publica = Pan American journal of public health

Sosa-Hernández O, Vázquez-Zamora C, Gutiérrez-Muñoz VH, Lugo-Zamudio GE, Cureño-Díaz MA.
PMID: 32973898
Rev Panam Salud Publica. 2020 Sep 23;44:e45. doi: 10.26633/RPSP.2020.45. eCollection 2020.

OBJECTIVE: Describe the results of the Program for the Rational Use of Antimicrobials at Mexico's Juárez Hospital.METHODS: An observational, cross-sectional, retrospective, descriptive study was designed. For the consumption of antimicrobial agents, data from January 2013 to December 2018 were...

Cite
Sosa-Hernández O, Vázquez-Zamora C, Gutiérrez-Muñoz VH, et al. Resultados del Programa de Uso Racional de Antimicrobianos en un hospital de México, 2013-2018. [Results of the Program for the Rational Use of Antimicrobials in a Mexican hospital, 2013-2018Resultados de um programa para o uso racional de antimicrobianos num hospital no México, 2013-2018]. Rev Panam Salud Publica. 2020;44:e45doi: 10.26633/RPSP.2020.45.
Sosa-Hernández, O., Vázquez-Zamora, C., Gutiérrez-Muñoz, V. H., Lugo-Zamudio, G. E., & Cureño-Díaz, M. A. (2020). Resultados del Programa de Uso Racional de Antimicrobianos en un hospital de México, 2013-2018. [Results of the Program for the Rational Use of Antimicrobials in a Mexican hospital, 2013-2018Resultados de um programa para o uso racional de antimicrobianos num hospital no México, 2013-2018]. Revista panamericana de salud publica = Pan American journal of public health, 44e45. https://doi.org/10.26633/RPSP.2020.45
Sosa-Hernández, Oscar, et al. "Resultados del Programa de Uso Racional de Antimicrobianos en un hospital de México, 2013-2018." [Results of the Program for the Rational Use of Antimicrobials in a Mexican hospital, 2013-2018Resultados de um programa para o uso racional de antimicrobianos num hospital no México, 2013-2018]. Revista panamericana de salud publica = Pan American journal of public health vol. 44 (2020): e45. doi: https://doi.org/10.26633/RPSP.2020.45
Sosa-Hernández O, Vázquez-Zamora C, Gutiérrez-Muñoz VH, Lugo-Zamudio GE, Cureño-Díaz MA. Resultados del Programa de Uso Racional de Antimicrobianos en un hospital de México, 2013-2018. [Results of the Program for the Rational Use of Antimicrobials in a Mexican hospital, 2013-2018Resultados de um programa para o uso racional de antimicrobianos num hospital no México, 2013-2018]. Rev Panam Salud Publica. 2020 Sep 23;44:e45. doi: 10.26633/RPSP.2020.45. eCollection 2020. Spanish. PMID: 32973898; PMCID: PMC7498298.
Copy Download .nbib Format: NLM
Impact of a pharmacist-driven antimicrobial stewardship program in a private hospital in Costa Rica.

Revista panamericana de salud publica = Pan American journal of public health

Díaz-Madriz JP, Cordero-García E, Chaverri-Fernández JM, Zavaleta-Monestel E, Murillo-Cubero J, Piedra-Navarro H, Hernández-Guillén M, Jiménez-Méndez T.
PMID: 32973905
Rev Panam Salud Publica. 2020 Sep 23;44:e57. doi: 10.26633/RPSP.2020.57. eCollection 2020.

OBJECTIVE: To measure the impact generated by the implementation of the pharmacy-driven antimicrobial stewardship program of the Clínica Bíblica Hospital.METHODS: This is a retrospective observational study that evaluates the consumption of antibiotics for the periods before and during implementation...

Cite
Díaz-Madriz JP, Cordero-García E, Chaverri-Fernández JM, et al. Impact of a pharmacist-driven antimicrobial stewardship program in a private hospital in Costa Rica. Rev Panam Salud Publica. 2020;44:e57doi: 10.26633/RPSP.2020.57.
Díaz-Madriz, J. P., Cordero-García, E., Chaverri-Fernández, J. M., Zavaleta-Monestel, E., Murillo-Cubero, J., Piedra-Navarro, H., Hernández-Guillén, M., & Jiménez-Méndez, T. (2020). Impact of a pharmacist-driven antimicrobial stewardship program in a private hospital in Costa Rica. Revista panamericana de salud publica = Pan American journal of public health, 44e57. https://doi.org/10.26633/RPSP.2020.57
Díaz-Madriz, José Pablo, et al. "Impact of a pharmacist-driven antimicrobial stewardship program in a private hospital in Costa Rica." Revista panamericana de salud publica = Pan American journal of public health vol. 44 (2020): e57. doi: https://doi.org/10.26633/RPSP.2020.57
Díaz-Madriz JP, Cordero-García E, Chaverri-Fernández JM, Zavaleta-Monestel E, Murillo-Cubero J, Piedra-Navarro H, Hernández-Guillén M, Jiménez-Méndez T. Impact of a pharmacist-driven antimicrobial stewardship program in a private hospital in Costa Rica. Rev Panam Salud Publica. 2020 Sep 23;44:e57. doi: 10.26633/RPSP.2020.57. eCollection 2020. PMID: 32973905; PMCID: PMC7498282.
Copy Download .nbib Format: NLM
Antimicrobial stewardship in rural and remote primary health care: a narrative review.

Antimicrobial resistance and infection control

Yau JW, Thor SM, Tsai D, Speare T, Rissel C.
PMID: 34256853
Antimicrob Resist Infect Control. 2021 Jul 13;10(1):105. doi: 10.1186/s13756-021-00964-1.

BACKGROUND: Antimicrobial resistance is an emerging problem worldwide and poses a significant threat to human health. Antimicrobial stewardship programmes are being implemented in health systems globally, primarily in hospitals, to address the growing threat of antimicrobial resistance. Despite the...

Cite
Yau JW, Thor SM, Tsai D, et al. Antimicrobial stewardship in rural and remote primary health care: a narrative review. Antimicrob Resist Infect Control. 2021;10(1):105doi: 10.1186/s13756-021-00964-1.
Yau, J. W., Thor, S. M., Tsai, D., Speare, T., & Rissel, C. (2021). Antimicrobial stewardship in rural and remote primary health care: a narrative review. Antimicrobial resistance and infection control, 10(1), 105. https://doi.org/10.1186/s13756-021-00964-1
Yau, Jun Wern, et al. "Antimicrobial stewardship in rural and remote primary health care: a narrative review." Antimicrobial resistance and infection control vol. 10,1 (2021): 105. doi: https://doi.org/10.1186/s13756-021-00964-1
Yau JW, Thor SM, Tsai D, Speare T, Rissel C. Antimicrobial stewardship in rural and remote primary health care: a narrative review. Antimicrob Resist Infect Control. 2021 Jul 13;10(1):105. doi: 10.1186/s13756-021-00964-1. PMID: 34256853; PMCID: PMC8278763.
Copy Download .nbib Format: NLM
Efficacy of an Er:YAG laser in the decontamination of dental implant surfaces: An in vitro study.

Journal of periodontology

AlMoharib HS, Steffensen B, Zoukhri D, Finkelman M, Gyurko R.
PMID: 33687796
J Periodontol. 2021 Nov;92(11):1613-1621. doi: 10.1002/JPER.20-0765. Epub 2021 Apr 06.

BACKGROUND: Emergence of peri-implant diseases led to the development of various methods for implant surface decontamination. This study was designed to compare the efficacy of biofilm removal from implant-like titanium surfaces by an erbium-doped yttrium-aluminum-garnet (Er:YAG) laser, titanium brush,...

Cite
AlMoharib HS, Steffensen B, Zoukhri D, et al. Efficacy of an Er:YAG laser in the decontamination of dental implant surfaces: An in vitro study. J Periodontol. 2021;92(11):1613-1621doi: 10.1002/JPER.20-0765.
AlMoharib, H. S., Steffensen, B., Zoukhri, D., Finkelman, M., & Gyurko, R. (2021). Efficacy of an Er:YAG laser in the decontamination of dental implant surfaces: An in vitro study. Journal of periodontology, 92(11), 1613-1621. https://doi.org/10.1002/JPER.20-0765
AlMoharib, Hani S, et al. "Efficacy of an Er:YAG laser in the decontamination of dental implant surfaces: An in vitro study." Journal of periodontology vol. 92,11 (2021): 1613-1621. doi: https://doi.org/10.1002/JPER.20-0765
AlMoharib HS, Steffensen B, Zoukhri D, Finkelman M, Gyurko R. Efficacy of an Er:YAG laser in the decontamination of dental implant surfaces: An in vitro study. J Periodontol. 2021 Nov;92(11):1613-1621. doi: 10.1002/JPER.20-0765. Epub 2021 Apr 06. PMID: 33687796.
Copy Download .nbib Format: NLM
Orthosiphon stamineus protects Caenorhabditis elegans against Staphylococcus aureus infection through immunomodulation.

Biology open

Kong C, Tan MW, Nathan S.
PMID: 24972867
Biol Open. 2014 Jun 27;3(7):644-55. doi: 10.1242/bio.20148334.

Amidst growing concerns over the spread of antibiotic-resistant Staphylococcus aureus strains, the identification of alternative therapeutic molecules has become paramount. Previously, we utilized a Caenorhabditis elegans-S. aureus screening platform to identify potential anti-infective agents from a collection of natural...

Cite
Kong C, Tan MW, Nathan S. Orthosiphon stamineus protects Caenorhabditis elegans against Staphylococcus aureus infection through immunomodulation. Biol Open. 2014;3(7):644-55doi: 10.1242/bio.20148334.
Kong, C., Tan, M. W., & Nathan, S. (2014). Orthosiphon stamineus protects Caenorhabditis elegans against Staphylococcus aureus infection through immunomodulation. Biology open, 3(7), 644-55. https://doi.org/10.1242/bio.20148334
Kong, Cin, et al. "Orthosiphon stamineus protects Caenorhabditis elegans against Staphylococcus aureus infection through immunomodulation." Biology open vol. 3,7 (2014): 644-55. doi: https://doi.org/10.1242/bio.20148334
Kong C, Tan MW, Nathan S. Orthosiphon stamineus protects Caenorhabditis elegans against Staphylococcus aureus infection through immunomodulation. Biol Open. 2014 Jun 27;3(7):644-55. doi: 10.1242/bio.20148334. PMID: 24972867; PMCID: PMC4154301.
Copy Download .nbib Format: NLM
Soap, water, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an ancient handwashing strategy for preventing dissemination of a novel virus.

PeerJ

Ijaz MK, Nims RW, de Szalay S, Rubino JR.
PMID: 34616601
PeerJ. 2021 Sep 17;9:e12041. doi: 10.7717/peerj.12041. eCollection 2021.

Public Health Agencies worldwide (World Health Organization, United States Centers for Disease Prevention & Control, Chinese Center for Disease Control and Prevention, European Centre for Disease Prevention and Control, etc.) are recommending hand washing with soap and water for...

Cite
Ijaz MK, Nims RW, de Szalay S, et al. Soap, water, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an ancient handwashing strategy for preventing dissemination of a novel virus. PeerJ. 2021;9:e12041doi: 10.7717/peerj.12041.
Ijaz, M. K., Nims, R. W., de Szalay, S., & Rubino, J. R. (2021). Soap, water, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an ancient handwashing strategy for preventing dissemination of a novel virus. PeerJ, 9e12041. https://doi.org/10.7717/peerj.12041
Ijaz, M Khalid, et al. "Soap, water, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an ancient handwashing strategy for preventing dissemination of a novel virus." PeerJ vol. 9 (2021): e12041. doi: https://doi.org/10.7717/peerj.12041
Ijaz MK, Nims RW, de Szalay S, Rubino JR. Soap, water, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an ancient handwashing strategy for preventing dissemination of a novel virus. PeerJ. 2021 Sep 17;9:e12041. doi: 10.7717/peerj.12041. eCollection 2021. PMID: 34616601; PMCID: PMC8451441.
Copy Download .nbib Format: NLM
CONJUGATION WITH SILVER NANOPARTICLES ENHANCES ANTI-ACANTHAMOEBIC ACTIVITY OF KAPPAPHYCUS ALVAREZII.

The Journal of parasitology

Walvekar S, Anwar A, Anwar A, Lai NJY, Yow YY, Khalid M, Siddiqui R, Khan NA.
PMID: 34265050
J Parasitol. 2021 Jul 01;107(4):537-546. doi: 10.1645/21-41.

Nanomedicine has the potential in enhancing the efficacy and bioavailability of anti-infective agents. Here we determined whether conjugation of the Malaysian cultivated seaweed Kappaphycus alvarezii with silver-conjugated nanoparticles enhanced anti-acanthamoebic properties. Silver-conjugated K. alvarezii were successfully synthesized, followed by...

Cite
Walvekar S, Anwar A, Anwar A, et al. CONJUGATION WITH SILVER NANOPARTICLES ENHANCES ANTI-ACANTHAMOEBIC ACTIVITY OF KAPPAPHYCUS ALVAREZII. J Parasitol. 2021;107(4):537-546doi: 10.1645/21-41.
Walvekar, S., Anwar, A., Anwar, A., Lai, N. J. Y., Yow, Y. Y., Khalid, M., Siddiqui, R., & Khan, N. A. (2021). CONJUGATION WITH SILVER NANOPARTICLES ENHANCES ANTI-ACANTHAMOEBIC ACTIVITY OF KAPPAPHYCUS ALVAREZII. The Journal of parasitology, 107(4), 537-546. https://doi.org/10.1645/21-41
Walvekar, Shweta, et al. "CONJUGATION WITH SILVER NANOPARTICLES ENHANCES ANTI-ACANTHAMOEBIC ACTIVITY OF KAPPAPHYCUS ALVAREZII." The Journal of parasitology vol. 107,4 (2021): 537-546. doi: https://doi.org/10.1645/21-41
Walvekar S, Anwar A, Anwar A, Lai NJY, Yow YY, Khalid M, Siddiqui R, Khan NA. CONJUGATION WITH SILVER NANOPARTICLES ENHANCES ANTI-ACANTHAMOEBIC ACTIVITY OF KAPPAPHYCUS ALVAREZII. J Parasitol. 2021 Jul 01;107(4):537-546. doi: 10.1645/21-41. PMID: 34265050.
Copy Download .nbib Format: NLM
A Smart Drug Delivery System Based on Biodegradable Chitosan/Poly(allylamine hydrochloride) Blend Films.

Pharmaceutics

Sarwar MS, Huang Q, Ghaffar A, Abid MA, Zafar MS, Khurshid Z, Latif M.
PMID: 32033138
Pharmaceutics. 2020 Feb 04;12(2). doi: 10.3390/pharmaceutics12020131.

The amalgamation of natural polysaccharides with synthetic polymers often produces fruitful results in the area of drug delivery due to their biodegradable and biocompatible nature. In this study, a series of blend films composed of chitosan (CS)/poly(allylamine hydrochloride) (PAH)...

Cite
Sarwar MS, Huang Q, Ghaffar A, et al. A Smart Drug Delivery System Based on Biodegradable Chitosan/Poly(allylamine hydrochloride) Blend Films. Pharmaceutics. 2020;12(2)doi: 10.3390/pharmaceutics12020131.
Sarwar, M. S., Huang, Q., Ghaffar, A., Abid, M. A., Zafar, M. S., Khurshid, Z., & Latif, M. (2020). A Smart Drug Delivery System Based on Biodegradable Chitosan/Poly(allylamine hydrochloride) Blend Films. Pharmaceutics, 12(2), . https://doi.org/10.3390/pharmaceutics12020131
Sarwar, Muhammad Sohail, et al. "A Smart Drug Delivery System Based on Biodegradable Chitosan/Poly(allylamine hydrochloride) Blend Films." Pharmaceutics vol. 12,2 (2020). doi: https://doi.org/10.3390/pharmaceutics12020131
Sarwar MS, Huang Q, Ghaffar A, Abid MA, Zafar MS, Khurshid Z, Latif M. A Smart Drug Delivery System Based on Biodegradable Chitosan/Poly(allylamine hydrochloride) Blend Films. Pharmaceutics. 2020 Feb 04;12(2). doi: 10.3390/pharmaceutics12020131. PMID: 32033138; PMCID: PMC7076397.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 198 entries